Fecha de publicación: -- Fuente: Labiotech Lugar: Podcast Our guest today is Dr. Per Lundin, CEO of Evox Therapeutics, a UK biotech using engineered exosomes to deliver genetic medicines directly into the brain.
The post How Evox Therapeutics is targeting CNS diseases with exosomes appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.